Clinical Study
Prospective Evaluation of Whole Genome MicroRNA Expression Profiling in Childhood Acute Lymphoblastic Leukemia
Table 1
Demographics, laboratory results, and response to the treatment in ALL patients.
| Sex | Female (%) | 21 (48.8) | Male (%) | 22 (51.2) | Mean age (year old) | | 6.8 ± 4.5 | White blood cells | Mean (mm3) | 47.930 | Range (mm3) | 487–474.000 | Subtype | T-lineage: 9 | | B-lineage: 34 | Blast BM | Mean (%) | 85 | Range (%) | 52–100 | Blast PB | Mean (%) | 51 | Range (%) | 2–100 |
| Characteristic | Status | (%) |
| Risk group | Standard risk | 13 (30) | Intermediate risk | 20 (47) | High risk | 10 (23) | Steroid response | Good | 36 | Poor | 7 | Response at 33 day | Remission | 43 | Not remission | 0 | Survival | Alive | 39 | Dead | 4 | Relapse | Yes | 0 | No | 39 | Dead | 4 |
|
|
ALL: acute lymphoblastic leukemia, BM: bone marrow, PB: peripheral blood.
|